JMP Securities raised the firm’s price target on Axon to $375 from $320 and keeps an Outperform rating on the shares. Axon is not only the top performer across the firm’s coverage year to date, but also yielded a number of positive data points after attending Axon Week 2024, its largest user conference to date, the firm says. JMP believes Axon VR training will be a critical component for continued TASER 10 adoption and product stickiness and feels that the recent Fusus acquisition builds on an already strong software story and further solidifies Axon’s position as a central platform for the public safety ecosystem.
Protect Your Portfolio Against Market Uncertainty
- Discover companies with rock-solid fundamentals in TipRanks' Smart Value Newsletter.
- Receive undervalued stocks, resilient to market uncertainty, delivered straight to your inbox.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on AXON: